A clinical trial to assess the combined effect of two drugs, Yogaraj Rasayana and Dhatri Loha in patients of Pandu (Iron Deficiency Anaemia)

Randomised Controlled Trial to assess the add on effect of Yogaraj Rasayana with Dhatri Loha in the Management of Pandu - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061727

Enrollment

168

Registered

2024-01-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of Pandu between age group of 16 to 50 years of either gender 2) Patients having lakshanas such as Panduta, Akshikuta Shoth, Hrutspandan, Shishirdwesha, Aarohan Ayas, Shrama, Bhrama and Daurbalya 3) Patients suffering from mild and moderate Iron deficiency Anaemia according to WHO having Hb% as follows - Males mild - 11.0 to 12.9 gm% Moderate - 8.0 to 10.9gm% Females - mild - 11.0 to 11.9 gm% Moderate - 8.0 to 10.9 gm%

Exclusion criteria

Exclusion criteria: 1) Anaemia due to blood loss - repeated miscarriages, at menarche, post-menopausal, through other orifices and GIT due to bleeding piles, malignancies etc. 2) Pregnancy and lactation 3) All types of Anaemia other than Iron Deficiency Anaemia 4) Other major systemic diseases like Diabetes Mellitus, Hypertension.

Design outcomes

Primary

Measure	Time frame
Rise in Hb%.Timepoint: at baseline and after 90 days (after the treatment)	—

Secondary

Measure	Time frame
Clinical symptoms will be assessed.Timepoint: at baseline, 15th day, 30th day, 45th day, 60th day, 75th day, 90th day.	—

Countries

India

Contacts

Public ContactVd Neeraja Satish Kulkarni

Tilak Ayurved Mahavidyalaya

sangeetap14@gmail.com09130774107

Outcome results